ncRNA name
hsa-miR-181a
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
Not available
Cancer name
Prostate Cancer
Cancer site
Prostate
Treatment type
Chemotherapy
Drug
Docetaxel
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MicroRNA-181a promotes docetaxel resistance in prostate cancer cells.
Tissue resource
prostate cancer cell lines C4-2B
prostate cancer paclitaxel-resistant cell lines TaxR
prostate cancer cell lines DU145
prostate cancer paclitaxel-resistant cell lines DU145-DTXR
Experiment
qRT-PCR,Western blot
Institute
Cedars-Sinai Medical Center
University of California Davis
Country
USA
Continent
Amercia